OVID THERAPEUTICS INC. - COMMON STOCK
3.0500
09-May-24 15:59:55
15 minutes delayed
Stocks
-0.0400
-1.29%
Today's range
3.0050 - 3.1043
ISIN
N/A
Source
NASDAQ
-
Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights
16 Aug 2021 08:00:02 By Nasdaq GlobeNewswire
-
08 Jul 2021 16:30:00 By Nasdaq GlobeNewswire
-
Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 Jul 2021 08:00:01 By Nasdaq GlobeNewswire
-
Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer
04 Jun 2021 08:00:00 By Nasdaq GlobeNewswire
-
26 May 2021 08:00:02 By Nasdaq GlobeNewswire
-
Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
13 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
12 May 2021 08:00:02 By Nasdaq GlobeNewswire
-
20 Apr 2021 08:00:02 By Nasdaq GlobeNewswire
-
OVID Provides Update on OV101 Program and the Prioritization of its Resources
19 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
-
30 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
-
15 Mar 2021 08:00:02 By Nasdaq GlobeNewswire